Thursday, November 18, 2004
Actos (pioglitazone) and Avandia (rosiglitazone) cause significant weight gain in 48-58% of patients
Actos (pioglitazone), an antidiabetic medicine, causes significant weight gain in 48 percent of patients who take it according to a study from Australia. Avandia (rosiglitazone), another antidiabetic medicine, causes significant weight loss in 58 percent of patients. Read the entire article | Email this article
QUICKLINKS AND VIEW OPITONS
QUOTE OF THE DAY
Books by Larry Hobbs available on Amazon
© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.